Value proposition

Developing predictive tools to de-risk clinical drug development

Cognivia is an innovator of analytical tools to optimize and accelerate the clinical development of new medicines. The privately held company was founded in 2013 by longtime colleagues with decades of experience in the pharmaceutical industry who set out to tackle some of the most challenging issues that prevent drugs from reaching the marketplace. Cognivia helps lessen risk and helps increase clinical trial success. It can help reduce the variability of study data by 30 percent. This can lead to fewer patients needed in a study, equating to less cost and time.

The company offers Placebell©TM, a solution that improved clinical trial assay sensitivity by characterizing and managing the individual placebo response in a variety of disease states where the placebo effect masks the true efficacy of potentially important therapies.